Cancer Imaging

Papers
(The TQCC of Cancer Imaging is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
How to develop a meaningful radiomic signature for clinical use in oncologic patients111
18F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanoma47
Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation43
Radiomics for glioblastoma survival analysis in pre-operative MRI: exploring feature robustness, class boundaries, and machine learning techniques38
What scans we will read: imaging instrumentation trends in clinical oncology35
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy35
MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins33
Predicting microvascular invasion in hepatocellular carcinoma: a deep learning model validated across hospitals31
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy30
Pharmacokinetic parameters and radiomics model based on dynamic contrast enhanced MRI for the preoperative prediction of sentinel lymph node metastasis in breast cancer29
Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer28
A CT-based radiomics nomogram for prediction of lung adenocarcinomas and granulomatous lesions in patient with solitary sub-centimeter solid nodules28
Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer28
Whole-body magnetic resonance imaging (WB-MRI) for cancer screening in asymptomatic subjects of the general population: review and recommendations28
The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI27
MRI features predict microvascular invasion in intrahepatic cholangiocarcinoma26
CT-based radiomics features in the prediction of thyroid cartilage invasion from laryngeal and hypopharyngeal squamous cell carcinoma25
A CT-based radiomics nomogram for distinguishing between benign and malignant bone tumours24
Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer24
Outcomes assessment in intrahepatic cholangiocarcinoma using qualitative and quantitative imaging features23
Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study23
Multi-view secondary input collaborative deep learning for lung nodule 3D segmentation22
Radiomic signature based on CT imaging to distinguish invasive adenocarcinoma from minimally invasive adenocarcinoma in pure ground-glass nodules with pleural contact22
Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer22
High resolution MRI-based radiomic nomogram in predicting perineural invasion in rectal cancer21
MRI-based radiomics to predict lipomatous soft tissue tumors malignancy: a pilot study21
Value of 18F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers21
Network-level functional connectivity alterations in chemotherapy treated breast cancer patients: a longitudinal resting state functional MRI study21
Dual-energy CT quantitative parameters for evaluating Immunohistochemical biomarkers of invasive breast cancer20
Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy19
Usefulness of 18F-FDOPA PET for the management of primary brain tumors: a systematic review of the literature18
A prospective analysis of the diagnostic accuracy of 3 T MRI, CT and endoscopic ultrasound for preoperative T staging of potentially resectable esophageal cancer18
The application of texture quantification in hepatocellular carcinoma using CT and MRI: a review of perspectives and challenges18
Long-axial field-of-view PET/CT: perspectives and review of a revolutionary development in nuclear medicine based on clinical experience in over 7000 patients18
Interreader reproducibility of the Neck Imaging Reporting and Data system (NI-RADS) lexicon for the detection of residual/recurrent disease in treated head and neck squamous cell carcinoma (HNSCC)18
Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study18
Dynamic contrast-enhanced MRI radiomics nomogram for predicting axillary lymph node metastasis in breast cancer17
Magnetic resonance imaging-based radiomics signature for preoperative prediction of Ki67 expression in bladder cancer17
Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer17
Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as g16
Interstitial lung abnormalities in patients with stage I non-small cell lung cancer are associated with shorter overall survival: the Boston lung cancer study16
CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas15
Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer – a first clinical approach15
Extracellular volume fraction measurement correlates with lymphocyte abundance in thymic epithelial tumors14
CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma14
Clinical and prognostic value of tumor volumetric parameters in melanoma patients undergoing 18F-FDG-PET/CT: a comparison with serologic markers of tumor burden and inflammation14
Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma14
MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy14
Prediction of microvascular invasion of hepatocellular carcinoma: value of volumetric iodine quantification using preoperative dual-energy computed tomography13
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study13
Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study13
FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma12
Feasibility and possible value of quantitative semi-automated diffusion weighted imaging volumetry of neuroblastic tumors12
Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatment12
Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model12
“Real-world” radiomics from multi-vendor MRI: an original retrospective study on the prediction of nodal status and disease survival in breast cancer, as an exemplar to promote discussion of the wider12
Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade12
Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET12
Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC)12
Gallbladder carcinoma: an initial clinical experience of reduced field-of-view diffusion-weighted MRI12
PET/CT variants and pitfalls in malignant melanoma12
Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography 12
Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma11
The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CT11
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise11
Clinical utility of FDG PET/CT for primary and recurrent papillary renal cell carcinoma11
FLAIR hyperintensity along the brainstem surface in leptomeningeal metastases: a case series and literature review11
PET/MR fusion texture analysis for the clinical outcome prediction in soft-tissue sarcoma11
Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib11
Magnetic resonance diffusion kurtosis imaging in differential diagnosis of benign and malignant renal tumors11
Extending the clinical capabilities of short- and long-lived positron-emitting radionuclides through high sensitivity PET/CT11
The role of resting-state functional MRI for clinical preoperative language mapping11
Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer10
Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC10
Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast10
Application of diffusion kurtosis tensor MR imaging in characterization of renal cell carcinomas with different pathological types and grades10
Automatic segmentation of head and neck primary tumors on MRI using a multi-view CNN10
Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?10
Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma10
Comparison of the pre-treatment functional MRI metrics’ efficacy in predicting Locoregionally advanced nasopharyngeal carcinoma response to induction chemotherapy9
Utility of the deep learning technique for the diagnosis of orbital invasion on CT in patients with a nasal or sinonasal tumor9
The prognostic value of 18F-FDG PET/CT intra-tumoural metabolic heterogeneity in pretreatment neuroblastoma patients9
Full automation of total metabolic tumor volume from FDG-PET/CT in DLBCL for baseline risk assessments9
The value of contrast‐enhanced ultrasound in determining the location of sentinel lymph nodes in breast cancer9
Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics9
Differentiating prostate cancer from benign prostatic hyperplasia using whole-lesion histogram and texture analysis of diffusion- and T2-weighted imaging9
Exploration of spatial distribution of brain metastasis from small cell lung cancer and identification of metastatic risk level of brain regions: a multicenter, retrospective study9
Associations between dynamic-contrast enhanced MRI and tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer9
Clustering subtypes of breast cancer by combining immunohistochemistry profiles and metabolism characteristics measured using FDG PET/CT9
Imaging features associated with H3 K27-altered and H3 G34-mutant gliomas: a narrative systematic review9
Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy9
The current status and future prospects for molecular imaging-guided precision surgery8
Post-PRRT scans: which scans to make and what to look for8
Imaging in metastatic breast cancer, CT, PET/CT, MRI, WB-DWI, CCA: review and new perspectives8
Native T1 mapping for differentiating the histopathologic type, grade, and stage of rectal adenocarcinoma: a pilot study8
Whole-body diffusion-weighted MRI of normal lymph nodes: prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort8
Hybrid imaging with [68Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer8
MRI-guided percutaneous thermoablation in combination with hepatic resection as parenchyma-sparing approach in patients with primary and secondary hepatic malignancies: single center long-term experie8
0.035416841506958